Chung-Chun Wu

660 total citations
21 papers, 545 citations indexed

About

Chung-Chun Wu is a scholar working on Oncology, Epidemiology and Physiology. According to data from OpenAlex, Chung-Chun Wu has authored 21 papers receiving a total of 545 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 10 papers in Epidemiology and 4 papers in Physiology. Recurrent topics in Chung-Chun Wu's work include Viral-associated cancers and disorders (18 papers), Herpesvirus Infections and Treatments (7 papers) and Histiocytic Disorders and Treatments (4 papers). Chung-Chun Wu is often cited by papers focused on Viral-associated cancers and disorders (18 papers), Herpesvirus Infections and Treatments (7 papers) and Histiocytic Disorders and Treatments (4 papers). Chung-Chun Wu collaborates with scholars based in Taiwan, Japan and Hong Kong. Chung-Chun Wu's co-authors include Jen‐Yang Chen, Chih‐Yeu Fang, Sheng‐Yen Huang, Ching-Hwa Tsai, Hui‐Yu Hsu, Sheng‐Ping Chou, Su‐Fang Lin, Yu‐Ting Chang, Ming‐Tsan Liu and Tamar Ben‐Porat and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Biochemistry.

In The Last Decade

Chung-Chun Wu

21 papers receiving 533 citations

Peers

Chung-Chun Wu

ONCOL

EPIDE

IMMUN

PFM

Sheng‐Yen Huang Taiwan

Meilan He United States

Ralf D. Hess Germany

Vishal Soni India

Yonggang Pei United States

Li-Kwan Chang Taiwan

Gao‐Hong Zhang China

Congqi Dai China

Yuqi Zhou China

Sheng‐Yen Huang Taiwan

Chung-Chun Wu

198 ×0.6

ONCOL

98 ×0.6

EPIDE

82 ×0.7

IMMUN

63 ×0.8

PFM

Citations per year, relative to Chung-Chun Wu Chung-Chun Wu (= 1×) peers Sheng‐Yen Huang

Countries citing papers authored by Chung-Chun Wu

Since Specialization

Citations

This map shows the geographic impact of Chung-Chun Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chung-Chun Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chung-Chun Wu more than expected).

Fields of papers citing papers by Chung-Chun Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chung-Chun Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chung-Chun Wu. The network helps show where Chung-Chun Wu may publish in the future.

Co-authorship network of co-authors of Chung-Chun Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Chung-Chun Wu. A scholar is included among the top collaborators of Chung-Chun Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chung-Chun Wu. Chung-Chun Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Chung-Chun, et al.. (2024). Epstein-Barr Virus BRLF1 Induces PD-L1 Expression in Nasopharyngeal Carcinoma Cells. Viral Immunology. 37(2). 115–123. 2 indexed citations

Wu, Chung-Chun, et al.. (2024). The Application of Emodin Treatment on Nasopharyngeal Carcinoma Therapy. Biomedicines. 12(3). 486–486. 2 indexed citations

Wu, Chung-Chun, et al.. (2023). Screening and identification of emodin as an EBV DNase inhibitor to prevent its biological functions. Virology Journal. 20(1). 148–148. 3 indexed citations

Wu, Chung-Chun, et al.. (2022). The Dietary Flavonol Kaempferol Inhibits Epstein–Barr Virus Reactivation in Nasopharyngeal Carcinoma Cells. Molecules. 27(23). 8158–8158. 9 indexed citations

Wu, Chung-Chun, et al.. (2019). Emodin Inhibits EBV Reactivation and Represses NPC Tumorigenesis. Cancers. 11(11). 1795–1795. 23 indexed citations

Wu, Chung-Chun, et al.. (2018). Perspective: Contribution of Epstein–Barr virus (EBV) Reactivation to the Carcinogenicity of Nasopharyngeal Cancer Cells. Cancers. 10(4). 120–120. 17 indexed citations

Wu, Chung-Chun, Chih‐Yeu Fang, Hui‐Yu Hsu, et al.. (2017). Inhibition of Epstein-Barr virus reactivation by the flavonoid apigenin. Journal of Biomedical Science. 24(1). 2–2. 47 indexed citations

Huang, Sheng‐Yen, Chung-Chun Wu, Sheng‐Ping Chou, et al.. (2017). Epstein-Barr virus BRLF1 induces genomic instability and progressive malignancy in nasopharyngeal carcinoma cells. Oncotarget. 8(45). 78948–78964. 18 indexed citations

Chen, Yen–Ju, Yulian Chen, Yao Chang, et al.. (2017). Epstein-Barr Virus Rta-Mediated Accumulation of DNA Methylation Interferes with CTCF Binding in both Host and Viral Genomes. Journal of Virology. 91(15). 7 indexed citations

10.

Wu, Chung-Chun, Chih‐Yeu Fang, Hui‐Yu Hsu, et al.. (2016). Luteolin inhibits Epstein-Barr virus lytic reactivation by repressing the promoter activities of immediate-early genes. Antiviral Research. 132. 99–110. 47 indexed citations

11.

Wu, Chung-Chun, Chih‐Yeu Fang, Hui‐Yu Hsu, et al.. (2016). EBV reactivation as a target of luteolin to repress NPC tumorigenesis. Oncotarget. 7(14). 18999–19017. 33 indexed citations

12.

Wu, Chung-Chun, et al.. (2014). Epstein-Barr virus BALF3 mediates genomic instability and progressive malignancy in nasopharyngeal carcinoma. Oncotarget. 5(18). 8583–8601. 51 indexed citations

13.

Huang, Sheng‐Yen, Chih‐Yeu Fang, Chung-Chun Wu, et al.. (2013). Reactive Oxygen Species Mediate Epstein-Barr Virus Reactivation by N-Methyl-N’-Nitro-N-Nitrosoguanidine. PLoS ONE. 8(12). e84919–e84919. 40 indexed citations

14.

Fang, Chih‐Yeu, Sheng‐Yen Huang, Chung-Chun Wu, et al.. (2012). The Synergistic Effect of Chemical Carcinogens Enhances Epstein-Barr Virus Reactivation and Tumor Progression of Nasopharyngeal Carcinoma Cells. PLoS ONE. 7(9). e44810–e44810. 37 indexed citations

15.

Wu, Chung-Chun, Ming‐Tsan Liu, Yu‐Ting Chang, et al.. (2009). Epstein–Barr Virus DNase (BGLF5) induces genomic instability in human epithelial cells. Nucleic Acids Research. 38(6). 1932–1949. 75 indexed citations

16.

Chen, Yiren, et al.. (2008). Epstein-Barr Virus Latent Membrane Protein 1 Represses DNA Repair through the PI3K/Akt/FOXO3a Pathway in Human Epithelial Cells. Journal of Virology. 82(16). 8124–8137. 56 indexed citations

17.

Wu, Chung-Chun, Tsuey-Ying Hsu, & Jen‐Yang Chen. (2005). Characterization of Three Essential Residues in the Conserved ATP-Binding Region of Epstein-Barr Virus Thymidine Kinase. Biochemistry. 44(12). 4785–4793. 5 indexed citations

18.

Wu, Chung-Chun, et al.. (2004). Identification and characterization of the conserved nucleoside-binding sites in the Epstein-Barr virus thymidine kinase. Biochemical Journal. 379(3). 795–803. 9 indexed citations

19.

Wu, Chung-Chun, Logan Harper, & Tamar Ben‐Porat. (1986). Molecular basis for interference of defective interfering particles of pseudorabies virus with replication of standard virus. Journal of Virology. 59(2). 308–317. 14 indexed citations

20.

Wu, Chung-Chun, Logan Harper, & Tamar Ben‐Porat. (1986). cis Functions involved in replication and cleavage-encapsidation of pseudorabies virus. Journal of Virology. 59(2). 318–327. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact